Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05984849 · ClinicalTrials.gov registry record · NA
Playing Game to Learn About Children's Vaccine Project
A NA study of Hpv and Vaccine-Preventable Diseases, sponsored by Michigan State University.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05984849: Recruiting NA study of Hpv and Vaccine-Preventable Diseases, sponsored by Michigan State University.
NCT05984849 is a NA study of Hpv and Vaccine-Preventable Diseases that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 180 participants, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05984849, a NA study of Hpv and Vaccine-Preventable Diseases, is actively recruiting participants, sponsored by Michigan State University.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
Primary Outcome
Assessed by the % of eligible individuals agreeing to participate
Conditions Studied
Interventions
- BEHAVIORAL vaccination game
Study Locations (1)
Arizona
- Community - Chandler
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2025-09 |
| Est. Completion | 2027-08 |
| Phase | NA |
What NCT05984849 shows while recruiting
NCT05984849 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 2,234-participant average among 24 other Hpv trials with a reported enrollment target (92% lower).
The record links to 2 conditions, with Hpv appearing as the primary indexed condition, and to 1 intervention - of which vaccination game is the first listed.
NCT05984849 reports a single indexed study location in Arizona.
Frequently Asked Questions
What is clinical trial NCT05984849 about?
NCT05984849 is a clinical study titled "Playing Game to Learn About Children's Vaccine Project". This proposed study aims to conduct timely research that promotes vaccine confidence and vaccination of one strongly recommended vaccine with suboptimal uptake rates: Human papillomavirus (HPV) in vulnerable and underserved youth aged 11-14.
What is the current status of trial NCT05984849?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2025-09. Estimated completion is 2027-08.
What conditions does trial NCT05984849 study?
This clinical trial studies the following conditions: Hpv, Vaccine-Preventable Diseases.
What interventions are being tested in trial NCT05984849?
The interventions under investigation include: vaccination game (BEHAVIORAL).
Who is sponsoring clinical trial NCT05984849?
This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05984849 being conducted?
This trial has 1 study location across Arizona. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hpv
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05984849's enrollment target sits among peer trials
180 13th of 24 higher than 12 of 24 other Hpv trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hpv trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
Stand Up 2 HPV: Standing Orders to Improve HPV Vaccination
RECRUITING · NA
-
HPV Self-Collection Program
RECRUITING · NA
-
Evaluation of the Q-Pad hrHPV Test System for Identifying Precancer
RECRUITING · NA
-
Prevención en Sus Manos: Feasibility of a Novel Community-Based Strategy to Improve Access to Cervical Cancer Screening
RECRUITING · NA
-
Treatment De-Escalation for Favorable Prognosis Human Papilloma Virus (HPV) or p16-Positive Oropharyngeal Cancer Receiving Definitive Radiotherapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia